Akamai Announces Pricing of Offering of Convertible Senior Notes Cambridge, MA | May 16, 2018
Akamai Technologies, Inc. (NASDAQ: AKAM) (Akamai) today announced that it has priced its private offering of $1 billion in aggregate principal amount of its convertible senior notes due 2025. The notes will be sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. In addition, Akamai has granted the initial purchasers of the notes an option to purchase up to an additional $150 million in aggregate principal amount of notes on the same terms and conditions. The sale of the notes is expected to close on May 21, 2018, subject to customary closing conditions.
The notes will be senior unsecured obligations of Akamai and will mature on May 1, 2025, unless earlier repurchased or converted in accordance with their terms prior to such date. The notes will bear interest at a rate of 0.125% per year, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on November 1, 2018. The notes will be convertible prior to January 1, 2025 only upon the occurrence of certain events and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date regardless of these events, in either case, into cash, shares of Akamais common stock or a combination of cash and shares of Akamais common stock at Akamais option. The conversion rate will initially be 10.5150 shares of Akamais common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $95.10 per share of Akamais common stock, subject to adjustments in certain events. The initial conversion price represents a premium of approximately 27.5% to the $74.59 per share closing price of Akamais common stock on May 16, 2018.
Akamai expects the net proceeds from this offering to be approximately $983.5 million (or approximately $1.13 billion if the initial purchasers exercise their option to purchase additional notes in full) after payment of the initial purchasers discounts and estimated offering expenses payable by Akamai.
Akamai intends to use $123.3 million of the proceeds to pay the cost of the convertible note hedge transactions described below (after such cost is partially offset by the proceeds from the sale of warrants pursuant to the warrant transactions described below). If the initial purchasers exercise their option to purchase the additional notes, Akamai expects to sell additional warrants to certain of the initial purchasers of the notes or their respective affiliates (the Option Counterparties) and use a portion of the proceeds from the sale of the additional notes, together with the proceeds from the additional warrant transactions, to enter into additional convertible note hedge transactions with the Option Counterparties.
Akamai intends to use the remaining net proceeds of the offering for working capital and general corporate purposes, including potential acquisitions and other strategic transactions.
In connection with the pricing of the notes, Akamai entered into convertible note hedge transactions and warrant transactions with the Option Counterparties. The convertible note hedge transactions will cover, subject to anti-dilution adjustments substantially similar to those applicable to the notes, the same number of shares of common stock that will initially underlie the notes, including any notes purchased by the initial purchasers pursuant to their option to purchase additional notes. The convertible note hedge transactions are expected generally to reduce the potential dilution with respect to Akamais common stock upon conversion of the notes and/or to offset any cash payments Akamai is required to make in excess of the principal amount of converted notes, as the case may be. The warrants will cover, subject to customary anti-dilution adjustments, the same number of shares of common stock. The warrant transactions could separately have a dilutive effect with respect to Akamais common stock to the extent that the market price per share of Akamais common stock exceeds the strike price of the warrants, unless Akamai elects, subject to certain conditions, to settle the warrants in cash.
In connection with establishing their initial hedge of the convertible note hedge and warrant transactions, the Option Counterparties or their respective affiliates expect to purchase shares of Akamai common stock and/or enter into various derivative transactions with respect to Akamai common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Akamai common stock or the notes at that time. In addition, the Option Counterparties or their respective affiliates may modify their hedge positions (and are likely to do so during any observation period related to a conversion of notes or following any repurchase of notes by Akamai on any fundamental change repurchase date or otherwise) by entering into or unwinding various derivatives with respect to Akamai's common stock and/or purchasing or selling common stock or other securities of Akamai in secondary market transactions following the pricing of the notes and prior to the maturity of the notes. This activity could also affect the then-prevailing market price of Akamai's common stock or the notes, which could affect the ability of holders to convert the notes and the amount and value of the consideration that holders receive upon conversion of the notes.
J.P. Morgan and Morgan Stanley are acting as joint book-running managers for the proposed offering. BofA Merrill Lynch is also acting as joint book-running manager. HSBC, SMBC Nikko and TD Securities are acting as co-managers for this o
